Title: | A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder |
---|---|
Sponsor: | Siyan Clinical Corporation |
Study Phase: | Phase 4 |
Study Type: | Interventional |
Intervention: | Drug: Vortioxetine (Vortioxetine 5-20mg) |
Primary Objective | The primary aim of this study is to evaluate the efficacy of Vortioxetine in an adult population with a diagnosis of PD. PD is generally treated with benzodiazepines which are very effective but have a high risk for addiction, fall, and cognitive impairment. There is still a need for better treatment for PD for longer term use. There are other drugs within the SSRI/SNRI class which have proven to be effective in treating patients with this diagnosis. |